Foregen
@foregen.org
Foregen is a non-profit organization founded to research and implement regenerative medical therapies for circumcised males. https://www.foregen.org/
Foregen made significant progress in August, with our latest implantation study now complete and all samples recovered intact with no rejection or inflammation. Recellularization work is also advancing toward the full foreskin scaffold. Read more:
Foregen Foreskin Regeneration Update: September 2026 — Foregen — Foregen
September 2026 update on foreskin regeneration research: the implantation study is complete with no rejection, and recellularization work is scaling up.
foregen.org
Our Q3 2026 donor call transcript is now live! Fibroblasts and stem cells are repopulating our decellularized scaffolds reliably. Keratinocytes are the remaining challenge in milestone three. Read the full call:
Foregen Q3 2026 Donor Call: Foreskin Regeneration Update — Foregen
Foregen's Q3 2026 donor call transcript: foreskin regeneration progress from the Slovakia lab, recellularization milestone 3, bioreactor work, and Q&A.
foregen.org
Check out our latest newsletter! Our research partners in Slovakia have been awarded two grants, including funding for a new confocal microscope that will be used for our work. Plus a new interview series and the latest on recellularization.
New Grants and Interviews | Foregen August 2026 Update — Foregen
Foregen's August 2026 update: two new grants for our Slovakian research partners, a new team interview series, and where keratinocyte recellularization stands.
foregen.org
Our Chief Operations Officer, Ryan Jones, sat down to explain the part of Foregen that supporters rarely see. The monthly research progress reports. The budgets and roadmaps. The decision to move research operations from Italy to Slovakia, and where every donated dollar goes.
The Operations Behind Foregen | A Conversation with COO Ryan Jones
Sit down with Chief Operations Officer Ryan Jones and hear how Foregen actually runs: the monthly research reports, the budgets and roadmaps, the move to Slovakia, and exactly where every donated dollar goes. Ryan explains how a graduate school class led him to discover that the World Health Organi
youtu.be
Sit down with founder Vincenzo Aiello and listen to the whole story behind Foregen: the early resistance, the science, and the mission to regenerate the human foreskin. youtu.be/jVo5V_0vcwc
The Story Behind Foregen | A Conversation with Founder Vincenzo Aiello
YouTube video by Foregen
youtu.be
What makes regenerating the foreskin so difficult, and what makes it possible? Our scientists answer your questions on camera, from decellularization to the bioreactor work happening right now. Watch the Q&A. youtu.be/ZQCM22PYM78?...
The Science Behind Foreskin Regeneration
YouTube video by Foregen
youtu.be
The case for routine infant circumcision being "healthier" doesn't survive close scrutiny. We walked through the actual evidence—HIV trials, cancer/UTI numbers, and what the @ameracadpeds.bsky.social own authors now say. foregen.org/updates/is-c...
Is Circumcision Healthier? What the Evidence Actually Says — Foregen
A close look at the research behind infant circumcision—HIV trials, AAP doubts, and why most of the world's doctors don't recommend it. Is it really healthier?
foregen.org
Ryan, Mason and Ali filming new material in the research lab! Stay tuned for an in-depth look at our research progress and the human beings making it happen.
We visited our research team in Slovakia, toured the lab, and recorded answers to the questions you submitted. Every step forward happens because of this community. Read the latest, or chip in to support our research: foregen.org/updates/insi...
Inside the Lab in Slovakia: Progress at the Bench and Your Questions Answered — Foregen
Our leadership visited Foregen's Slovakia lab to see recellularization progress firsthand and recorded the research team answering your top questions.
foregen.org
Our redesigned website is live, and Foregen presented at the 2026 Intact Global Conference. Catch up on last month's progress and what's coming next. foregen.org/updates/our-...
Our New Website Is Live | Foregen May 2026 Update — Foregen
Foregen's redesigned website is live, our team presented at the Intact Global Conference, and a Slovakia site visit and recellularization fundraiser are next.
foregen.org
Our work is featured in @nymag.com this week. The demand for foreskin restoration is very real. That's why we're developing a regenerative medicine solution to biologically restore the foreskin's form, function, and sensation.
New York Magazine@nymag.com · 5mo agoAs circumcision rates in the United States reach an all-time low, some men who hate their snipped penises are going to great lengths to re-create foreskin. Most try manually stretching their skin, while others are turning to experimental surgery.
Our new website is live. A fresh look at who we are, what we're building, and why. Explore our research milestones, meet the team, and learn how regenerative medicine is making foreskin restoration a reality. foregen.org
Foreskin Regeneration Research
Foregen is a nonprofit pioneering regenerative medicine to restore the foreskin in form, function, and sensation. Follow our progress and support the science.
foregen.org
Recellularization is scaling to larger tissue formats, bioreactor development is moving forward, and our community submitted 139 questions for an upcoming Q&A with our chief bioengineer. Read the full update: www.foregen.org/commentarium-articles/april-1st-2026
We're giving you the chance to ask Foregen's Chief Bioengineer Ján Kováč anything about the science behind foreskin regeneration. Submit your question and it could be featured in an upcoming Q&A video. forms.gle/TWyLe3zjfVP3...
Your Questions for Foregen's Chief Bioengineer
This May, we're heading to Slovakia to sit down with Ján Kováč, Foregen's Chief Bioengineer, for a special recorded Q&A session. This is your chance to ask Ján anything about the science behind foresk...
forms.gle
Our March newsletter is live! From pilot recellularization to full-scale testing, biomechanical analysis in Austria, and ongoing in vivo safety studies, our research team in Slovakia continues to make progress toward clinical trials. Read the full update: www.foregen.org/commentarium...
Foregen: Scaling Up Recellularization, Unprecedented Biomechanics Data, and In Vivo Safety Testing - Larger samples, rigorous testing, and long-term safety data from our labs in Slovakia and Austria.
Foregen's March 2026 newsletter: recellularization scales to larger samples, biomechanical testing completed in Graz, and in vivo safety studies progress toward publication.
foregen.org
2025 pushed Foregen forward in a big way: real progress in the lab, new peer-reviewed science, and a community that showed up when it mattered most. If you want the clearest picture yet of what we accomplished and what’s coming next, read our Year in Review. www.foregen.org/commentarium...
Foregen: A Year in Review: 2025 - Substantial Research Progress and Fundraising Success
Foregen’s 2025 Year in Review highlights major scientific and community milestones, including the launch of our new preclinical research collaboration with Dr. Stanislav Žiaran in Bratislava, a May si...
foregen.org
Check out our latest newsletter, where we discuss our successful pilot recellularization test and our latest lab tour video! www.foregen.org/commentarium...
Pilot recellularization success! We’ve verified the attachment and proliferation of fibroblasts, keratinocytes, and stem cells across 50+ samples using confocal microscopy. 🔬 This proves our scaffolds are non-toxic and ready for new cells. Read more: www.foregen.org/commentarium...
Foregen: Pilot Recellularization Results - Confirming scaffold viability and cell growth
Foregen achieves successful pilot recellularization across 50 samples. Fibroblasts and stem cells verified on scaffolds via confocal microscopy.
foregen.org
HUGE NEWS: We raised $62,959 for our December match campaign! 🎉 We’re automating our bioreactors to build the "bioreactor farm" model. Plus, we’re wrapping Milestone 3 and moving to Milestone 4—the FINAL preclinical stage! Read more: www.foregen.org/commentarium-articles/january-4th-2026
Foregen: January 4th, 2026 - $62,959 Raised: A Fundraising Win for the New Year!
Foregen raises $62,959 to fund bioreactor scaling, prepares to complete Milestone 3, and moves toward the final preclinical phase: Milestone 4
foregen.org
Our community raised an incredible $34,748 for our December match campaign—nearly $10k over our target! With the match, almost $60,000 is now fueling the automation of our bioreactors. This is the foundation for our "bioreactor farm" and clinical scaling. www.foregen.org/commentarium...
Foregen: December Matching Campaign Success! - We crushed our goal! Thank you for raising nearly $60k with the match.
Foregen surpasses its $25k goal, raising $34,748 to fund bioreactor automation. Learn how this success accelerates our
foregen.org
We have officially reached 80% of our matching campaign goal! We only have 20% left to go—help us cross the finish line today. Remember: every dollar you give is DOUBLED! www.foregen.org/donate
We're halfway through the month! So far, we've raised $15,616, which is 62% of our overall goal. We are so grateful for the support you've given so far. Make a donation today and you can double your impact! www.foregen.org/donate
Foregen@foregen.org · 10mo agoWe've launched a $25K MATCHING CAMPAIGN to support the development of our bioreactor! Through the end of the year, each donation you make to Foregen will be matched, dollar-for-dollar. Check out our latest newsletter for more! www.foregen.org/commentarium...
Check out our latest Conference Call for an update on our research progress and an informative Q&A with donors! youtu.be/_rhCA1kbMXY
Q4 2025 Conference Call with Founder, CSO, and COO
YouTube video by Foregen
youtu.be
We've launched a $25K MATCHING CAMPAIGN to support the development of our bioreactor! Through the end of the year, each donation you make to Foregen will be matched, dollar-for-dollar. Check out our latest newsletter for more! www.foregen.org/commentarium...
Check out this month's newsletter for updates on the recent publication of an animal trials article, progress on our pre-clinical research project, and our latest YouTube video! www.foregen.org/commentarium...
Foregen: November 1st, 2025 - Rat trial results are published! Plus: Final safety testing is nearing completion in the lab
Foregen hits major milestones in pre-clinical research: Dr. Palumbo's rat trial results are published, and decellularization is confirmed successful on all 20 samples.
foregen.org
Inside the Lab: Episode Two is out! Join us as we explore our partner's bioreactor technology and unique approaches to regenerative medicine. youtu.be/7WtN8HYsXbk
Foregen Inside the Lab: Episode Two
YouTube video by Foregen
youtu.be
An upcoming article on infant circumcision policy is soon to be published in the Journal of Medical Ethics. The central argument powerfully aligns with Foregen's ethics and marks an important moment in the shifting dynamics of the infant circumcision debate. www.foregen.org/commentarium...
Foregen: New Article in Major Journal Highlights Flaws in American Circumcision Policy - The need for transparency on non-medical factors in circumcision policy.
Foregen supports new JME article by Max Buckler arguing major medical bodies (AAP) influence circumcision policies with cultural and non-medical biases, violating non-maleficence. Demand transparency ...
foregen.org
The profound sense of loss for circumcised men is real. Foregen is building the scientific solution for men seeking to reclaim their complete body through advanced regenerative medicine. Learn more: www.foregen.org/commentarium...
It's not just about the research, it's about the dedication. The efforts of our team, including Ph.D. student and bioengineer Ján Kovác, have laid a strong foundation for our progress. Learn more in our latest post! www.foregen.org/commentarium...
